JP2024545873A5 - - Google Patents
Info
- Publication number
- JP2024545873A5 JP2024545873A5 JP2024533988A JP2024533988A JP2024545873A5 JP 2024545873 A5 JP2024545873 A5 JP 2024545873A5 JP 2024533988 A JP2024533988 A JP 2024533988A JP 2024533988 A JP2024533988 A JP 2024533988A JP 2024545873 A5 JP2024545873 A5 JP 2024545873A5
- Authority
- JP
- Japan
- Prior art keywords
- itga1
- function
- nucleic acid
- lung disease
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291194P | 2021-12-17 | 2021-12-17 | |
| US63/291,194 | 2021-12-17 | ||
| PCT/US2022/081750 WO2023114969A2 (en) | 2021-12-17 | 2022-12-16 | Treatment of lung conditions with integrin subunit alpha 1 (itga1) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545873A JP2024545873A (ja) | 2024-12-13 |
| JP2024545873A5 true JP2024545873A5 (https=) | 2025-12-09 |
Family
ID=85158395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533988A Pending JP2024545873A (ja) | 2021-12-17 | 2022-12-16 | インテグリンサブユニットα１（ＩＴＧＡ１）阻害剤による肺の状態の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230192864A1 (https=) |
| EP (1) | EP4448766A2 (https=) |
| JP (1) | JP2024545873A (https=) |
| CN (1) | CN118804976A (https=) |
| CA (1) | CA3240997A1 (https=) |
| MX (1) | MX2024007460A (https=) |
| WO (1) | WO2023114969A2 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73300C2 (en) * | 1999-06-01 | 2005-07-15 | Biogen Inc | Use of composition containing homolog of antibody antagonizing interaction between integrin with alpha-4 subunit and its ligand for treating fibrosis |
| WO2006124269A2 (en) * | 2005-05-16 | 2006-11-23 | Amgen Fremont Inc. | Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders |
| JP2017510552A (ja) * | 2014-02-07 | 2017-04-13 | イーフェクター セラピューティクス， インコーポレイテッド | 線維性疾患を治療するための方法 |
| EP3458157A4 (en) * | 2016-05-19 | 2020-05-27 | Momenta Pharmaceuticals, Inc. | METHOD FOR TREATING DISEASES RELATING TO FIBROSE AND SYSTEMIC Sclerosis |
| WO2018159432A1 (ja) * | 2017-03-03 | 2018-09-07 | ロート製薬株式会社 | 間葉系幹細胞及び医薬組成物 |
| CN111643649A (zh) * | 2020-05-20 | 2020-09-11 | 博奥生物集团有限公司 | 防治免疫相关疾病的中药材及其组合物 |
-
2022
- 2022-12-16 CN CN202280082782.0A patent/CN118804976A/zh active Pending
- 2022-12-16 CA CA3240997A patent/CA3240997A1/en active Pending
- 2022-12-16 US US18/067,085 patent/US20230192864A1/en active Pending
- 2022-12-16 MX MX2024007460A patent/MX2024007460A/es unknown
- 2022-12-16 EP EP22851448.5A patent/EP4448766A2/en active Pending
- 2022-12-16 JP JP2024533988A patent/JP2024545873A/ja active Pending
- 2022-12-16 WO PCT/US2022/081750 patent/WO2023114969A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230235325A1 (en) | Compositions and Methods for Treating Huntington's Disease and Related Disorders | |
| KR102501980B1 (ko) | 화학적으로 변형된 단일 가닥 rna-편집 올리고뉴클레오타이드 | |
| Agustín-Pavón et al. | Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice | |
| US20190062740A1 (en) | COMPOSITIONS AND METHODS OF USING piRNAS IN CANCER DIAGNOSTICS AND THERAPEUTICS | |
| US12612665B2 (en) | Long non-coding RNA LETN serving as tumor marker and therapeutic target point | |
| JP7553036B2 (ja) | ｓｎｏＲＮＡの発現抑制剤を有効成分とするがん増殖抑制剤 | |
| JP2021522836A (ja) | スプライスオパシーの軽減、及びｒｎａドミナンス障害の治療のための組成物及び方法 | |
| JP2022523301A5 (https=) | ||
| JP2022514567A5 (https=) | ||
| JP2023531935A5 (https=) | ||
| Pappadà et al. | Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells | |
| JP2024545873A5 (https=) | ||
| JP7032140B2 (ja) | 嚢胞性線維症の処置のための方法及び医薬組成物 | |
| CN116889627A (zh) | 用固醇调节元件结合转录因子1(srebf1)抑制剂治疗脂质水平升高 | |
| JP2022525545A5 (https=) | ||
| JP6910305B2 (ja) | 再生医療のためのベクターおよび方法 | |
| CN112662671A (zh) | 靶向SMN2启动子区甲基化位点nt-290所在区域的反义寡核苷酸 | |
| JP2024535110A5 (https=) | ||
| JP2022525546A5 (https=) | ||
| CN112779252B (zh) | 靶向SMN2启动子区MeCP2结合的关键甲基化区域的反义寡核苷酸 | |
| US20230192864A1 (en) | Treatment Of Lung Conditions With Integrin Subunit Alpha 1 (ITGA1) Inhibitors | |
| AU2022304677A1 (en) | Methods of treating asthma with solute carrier family 27 member 3 (slc27a3) inhibitors | |
| JP2001514862A (ja) | Ｄｎａシトシン−５メチルトランスフェラーゼのモジュレーターおよびその使用法 | |
| JP2024508824A5 (https=) | ||
| IL303753A (en) | Preparations for use in the treatment of CHD2 HAPLOINSUFFICIENCY and methods for detection |